Biomednewsbreaks - Helus Pharma(TM) (NASDAQ: HELP) (Cboe CA: HELP) Reports Q3 2025 Results, Advances Phase 3 And Phase 2 Programs February 14, 2026 mental-health ONLY AVAILABLE IN PAID PLANS. Originally reported by menafn. Read more Source: https://menafn.com/1110738234/Biomednewsbreaks-Helus-PharmaTM-NASDAQ-HELP-Cboe-CA-HELP-Reports-Q3-2025-Results-Advances-Phase-3-And-Phase-2-Programs
